Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
Launched by M.D. ANDERSON CANCER CENTER · Jun 4, 2024
Trial Information
Current as of September 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a person's background and financial situation can affect their options for bone marrow transplantation, specifically when it comes to choosing a donor. The trial aims to understand if these factors influence patients' chances of receiving bone marrow cells that are genetically similar to theirs, which can be important for the success of the transplant.
To be eligible for the trial, participants need to be at least 18 years old and be considered for an allogeneic transplantation, which is a procedure where a patient receives stem cells from a donor. The trial is currently looking for participants and will include individuals of any gender and age from 18 years and older. If you join the trial, you’ll help researchers learn more about these important differences in treatment options, which can lead to better care for everyone in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. ≥ 18 years of age.
- • 2. Candidate for allogeneic transplantation
- Exclusion Criteria:
- • 1) Allogeneic stem cell transplantation not medically indicated.
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Warren Fingrut, MD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported